Werner Coussement
Overview
Explore the profile of Werner Coussement including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
4
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shkedy Z, Straetemans R, Molenberghs G, Desmidt M, Vinken P, Goeminne N, et al.
J Biopharm Stat
. 2017 Sep;
15(2):205-223.
PMID: 28881177
During preclinical drug development, the immune system is specifically evaluated after prolonged treatment with drug candidates, because the immune system may be an important target system. The response of antibodies...
2.
Ceelen L, de Zwart L, Voets M, Hillewaert V, Monbaliu J, Teuns G, et al.
Am J Forensic Med Pathol
. 2011 Mar;
33(2):119-23.
PMID: 21389904
Postmortem redistribution of fentanyl in the rabbit was investigated after application of the 50-μg/h Durogesic pain patch. Patches were applied for 48 hours. Two cycles of patch administration were used...
3.
Hendriks R, Van den Eynde H, Coussement W
Ann Ist Super Sanita
. 2009 Apr;
44(4):407-8.
PMID: 19352005
Compliance with the Organisation for Economic Co-operation and Development (OECD) principles of good laboratory practice (GLP) is discussed in particular as regards the responsibility of the management of a test...
4.
De Schaepdrijver L, Rouan M, Raoof A, Bailey G, de Zwart L, Monbaliu J, et al.
Reprod Toxicol
. 2008 Jun;
26(1):54-5.
PMID: 18514481
With the growing experience in the conduct of juvenile toxicity studies for multiple classes of compound, the 'case-by-case' approach has become under much more pressure. Instead, a general screen or...
5.
Jonghe S, Verbeeck J, Vinken P, Lammens L, Starckx S, Lachau-Durand S, et al.
Toxicol Pathol
. 2008 Mar;
36(2):321-9.
PMID: 18367644
Dietary dosing of the non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC125, under development for treatment of HIV-1, resulted in a syndrome in male mice in a previous experiment that was termed...
6.
Shkedy Z, Straetemans R, Molenberghs G, Desmidt M, Vinken P, Goeminne N, et al.
J Biopharm Stat
. 2005 Mar;
15(2):205-23.
PMID: 15796290
During preclinical drug development, the immune system is specifically evaluated after prolonged treatment with drug candidates, because the immune system may be an important target system. The response of antibodies...